dc.contributor.author | Ongen, Betigül | |
dc.contributor.author | Ilktac, M. | |
dc.contributor.author | Nazik, H. | |
dc.date.accessioned | 2021-03-02T22:16:46Z | |
dc.date.available | 2021-03-02T22:16:46Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Nazik H., Ilktac M., Ongen B., "Prevalence of qnrA, qnrB, qnrS and aac(6 ')-Ib-cr (in qnr-Positive Isolates) Among ESBL-Positive and/or Ciprofloxacin-Resistant Isolates in Turkey", JOURNAL OF CHEMOTHERAPY, cilt.21, sa.2, ss.219-221, 2009 | |
dc.identifier.issn | 1120-009X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0bc13549-7c1c-40c5-8823-5e886757e7e6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/13570 | |
dc.identifier.uri | https://doi.org/10.1179/joc.2009.21.2.219 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Patoloji | |
dc.subject | Eczacılık | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.subject | İmmünoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | PATOLOJİ | |
dc.subject | Biyoloji ve Biyokimya | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Biyokimya | |
dc.title | Prevalence of qnrA, qnrB, qnrS and aac(6 ')-Ib-cr (in qnr-Positive Isolates) Among ESBL-Positive and/or Ciprofloxacin-Resistant Isolates in Turkey | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CHEMOTHERAPY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 21 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 219 | |
dc.identifier.endpage | 221 | |
dc.contributor.firstauthorID | 45188 | |